Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

CDK9-IN-42

CDK9-IN-42 is a potent and selective CDK9 inhibitor with an IC50 value of 3.8 nM. It inhibits cancer cell growth and induces apoptosis by downregulating Myc-1 and c-Myc. CDK9-IN-42 is applicable in cancer research, including studies on breast cancer and lung cancer.

Product Specifications

Storage Conditions

-20°C

Notes

For research use only.

Available Sizes

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

Recombinant Human Advanced Glycosylation End Product-Specific Receptor
MBS143449-01 0.002 mg

Recombinant Human Advanced Glycosylation End Product-Specific Receptor

Sign In for Pricing
View Details
Recombinant Human Advanced Glycosylation End Product-Specific Receptor
MBS143449-02 0.01 mg

Recombinant Human Advanced Glycosylation End Product-Specific Receptor

Sign In for Pricing
View Details
Recombinant Human Advanced Glycosylation End Product-Specific Receptor
MBS143449-03 1 mg

Recombinant Human Advanced Glycosylation End Product-Specific Receptor

Sign In for Pricing
View Details
Recombinant Human Advanced Glycosylation End Product-Specific Receptor
MBS143449-04 5x 1 mg

Recombinant Human Advanced Glycosylation End Product-Specific Receptor

Sign In for Pricing
View Details
Fzr1 3'UTR Lenti-reporter-Luc Vector
21117084 1.0 µg

Fzr1 3'UTR Lenti-reporter-Luc Vector

Sign In for Pricing
View Details
CCRL1 Peptide - C-terminal region
orb2011333 100 µg

CCRL1 Peptide - C-terminal region

Sign In for Pricing
View Details